Paclitaxel and suramin-loaded core/shell microspheres in the treatment of brain tumors

被引:76
作者
Nie, Hemin [1 ]
Fu, Yilong [1 ]
Wang, Chi-Hwa [1 ]
机构
[1] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117576, Singapore
关键词
Paclitaxel; Suramin; Microsphere; Drug delivery; Chemotherapy; In vivo; CONTROLLED DELIVERY; LOCAL CHEMOTHERAPY; PHASE-II; IN-VITRO; CARMUSTINE; MICROPARTICLES; NANOPARTICLES; GLIOBLASTOMA; IMPLANTS; EFFICACY;
D O I
10.1016/j.biomaterials.2010.07.080
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
This work presents a modified method, namely coaxial electrohydrodynamic atomization, for the preparation of microspheres with distinct core/shell structures. This allows the encapsulation of two drugs with different characteristics in hydrophilic properties in one single step. Variation of ratios between outer flow and inner flow produces polymer microspheres with different core/shell ratios, and consequently results in variable release rates of drugs. Significant changes in release patterns were demonstrated when the distributions of the two drugs in microspheres were swapped. Moreover, cell culture experiments and animal experiments have been carried out to testify the performances of different microspheres in cytotoxicity, cellular apoptosis in vitro and tumor inhibition against subcutaneous U87 glioma xenograft in BALB/c nude mice. These findings present the advantages and possible application of this kind of multi-drug release system in treating brain tumors. Moreover, the release rates and characteristic sequences of multi-drugs can be tailored and tuned according to treatment necessity and applied in treating other kinds of tumors. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:8732 / 8740
页数:9
相关论文
共 39 条
  • [21] Formulation and characterization of poly (β amino ester) microparticles for genetic vaccine delivery
    Little, SR
    Lynn, DM
    Puram, SV
    Langer, R
    [J]. JOURNAL OF CONTROLLED RELEASE, 2005, 107 (03) : 449 - 462
  • [22] MINNITI CP, 1992, CANCER RES, V52, P1830
  • [23] Lysine-based peptide-functionalized PLGA foams for controlled DNA delivery
    Nie, Hemin
    Khew, Shih Tak
    Lee, Lai Yeng
    Poh, Kai Ling
    Tong, Yen Wah
    Wang, Chi-Hwa
    [J]. JOURNAL OF CONTROLLED RELEASE, 2009, 138 (01) : 64 - 70
  • [24] Niero A, 1999, CLIN CANCER RES, V5, P2213
  • [25] Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas
    Ohgaki, H
    Kleihues, P
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2005, 64 (06) : 479 - 489
  • [26] Genetic pathways to glioblastoma:: A population-based study
    Ohgaki, H
    Dessen, P
    Jourde, B
    Horstmann, S
    Nishikawa, T
    Di Patre, PL
    Burkhard, C
    Schüler, D
    Probst-Hensch, NM
    Maiorka, PC
    Baeza, N
    Pisani, P
    Yonekawa, Y
    Yasargil, MG
    Lütolf, UM
    Kleihues, P
    [J]. CANCER RESEARCH, 2004, 64 (19) : 6892 - 6899
  • [27] SURAMIN PREVENTS NEOVASCULARIZATION AND TUMOR-GROWTH THROUGH BLOCKING OF BASIC FIBROBLAST GROWTH-FACTOR ACTIVITY
    PESENTI, E
    SOLA, F
    MONGELLI, N
    GRANDI, M
    SPREAFICO, F
    [J]. BRITISH JOURNAL OF CANCER, 1992, 66 (02) : 367 - 372
  • [28] PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465
  • [29] Poly(ethylene oxide)-modified poly(β-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery
    Potineni, A
    Lynn, DM
    Langer, R
    Amiji, MM
    [J]. JOURNAL OF CONTROLLED RELEASE, 2003, 86 (2-3) : 223 - 234
  • [30] Phase II study of paclitaxel in patients with recurrent malignant glioma
    Prados, MD
    Schold, SC
    Spence, AM
    Berger, MS
    McAllister, LD
    Mehta, MP
    Gilbert, MR
    Fulton, D
    Kuhn, J
    Lamborn, K
    Rector, DJ
    Chang, SM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (08) : 2316 - 2321